SectorPharmaceutical
Established Date13/06/1997
Listing Date05/11/2021
ExchangeNASDAQ Stock Exchange
Full-time Employees11
Fiscal Year Ends31/12
Security TypeCommon stock
Office address40 Marcus Drive, Suite 1, Melville, New York 11747
Business
IntroductionBiorestorative Therapies, Inc. was incorporated in Nevada on June 13, 1997. The company is currently working on a Disc/Spine program with a preliminary research therapeutic product called BRTX-100. In March 2022, a US patent was issued in the Disc/Spine Program. The company submitted an IND application to the U.S. Food and Drug Administration (FDA) for authorization to begin a Phase 2 clinical trial investigating the use of BRTX-100 for chronic low back pain caused by degenerative disc disease. The company has received such authorization from the FDA and has commenced such clinical trials.
